4,765
STUDY VISITS
2,184
PATIENTS
144
GASTROENTEROLOGISTS
Participating Sites
CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
Outcome measures in the CorEvitas IBD Registry.
Among the variables we collect, some of the key outcome measures to inform your research include:
Clinician Reported Outcomes
- Disease location and phenotype
- IBD-related extraintestinal manifestations
Calculated Measures
- Harvey-Bradshaw Index (Crohn’s disease)
- Simple Clinical Colitis Activity Index (SCCAI) (Ulcerative colitis)
- Mayo Score (partial) (Ulcerative colitis)
- Simple Endoscopic Score (SES-CD) (Crohn’s disease, if endoscopic score provided)
- Mayo Severity Index (if flexible proctosigmoidoscopy findings provided)
Patient Reported Outcomes
- PROMIS – Anxiety, Depression, Fatigue, Sleep Disturbance, Pain Interference
- Work Productivity and Activity Impairment (WPAI)
Our Publications